The ratings agency has affirmed BBB ratings for Thermo Fisher's long term issuer default rating, senior notes, and bank revolving credit facility.
The ratings firm noted Thermo Fisher's efforts to bring down its debt and said that the company could resume bolt-on acquisitions next year.
The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.
NEW YORK (GenomeWeb News) – Standard & Poor's on Thursday raised Life Technologies' corporate credit rating and the issue-level rating on the firm's secured and unsecured debt to BBB+.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Fitch Ratings late on Tuesday affirmed several ratings of BBB+ for Agilent Technologies.
Morningstar said that the rating reflects its negative view of the genetic analysis instrument business and potential competitive pressure for Illumina.
The rating agency raised its outlook on Agilent to 'positive' from 'stable' due to "greater confidence in Agilent's operating and financial profile."
S&P cited Bio-Rad's "solid operating performance and cash flow generation" in announcing the upgrade.
Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.
The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.
CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.
In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.